Enzene Inc.Enzene an integrated global CDMO, offers services spanning discovery, development and commercial supply. Its patented fully-connected continuous manufacturing(TM) (FCCM(TM)) platform, EnzeneX(TM), is validated for commercial biologics supply and demonstrates significantly increased production yields and reduced costs. Enzene aims to lower mAb production costs below $40/gram by 2025. Our microbial and mammalian drug substance plants, as well as our sterile fill & finish plant in India are EU-GMP certified.Visit www.enzene.com.
